CRDA logo

Croda International Plc Stock Price

LSE:CRDA Community·UK£4.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 49 Fair Values set on narratives written by author

CRDA Share Price Performance

UK£32.20
6.71 (26.32%)
UK£35.80
Fair Value
UK£32.20
6.71 (26.32%)
10.0% undervalued intrinsic discount
UK£35.80
Fair Value
Price UK£32.20
AnalystConsensusTarget UK£35.80
AnalystLowTarget UK£28.65
AnalystHighTarget UK£42.96

CRDA Community Narratives

·
Fair Value UK£35.8 10.0% undervalued intrinsic discount

CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year

0users have liked this narrative
0users have commented on this narrative
25users have followed this narrative
·
Fair Value UK£28.65 12.4% overvalued intrinsic discount

Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value UK£42.96 25.1% undervalued intrinsic discount

Sustainable Biotech Ingredients Will Capture Global Specialty Demand

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
UK£35.8
10.0% undervalued intrinsic discount
Revenue
4.57% p.a.
Profit Margin
12.71%
Future PE
25.1x
Price in 2029
UK£44.82

Trending Discussion

No trending discussion available.

Updated Narratives

CRDA logo

CRDA: Recent Repricing Signals Future Re Rating Potential At 3,400 Level

Fair Value: UK£42.96 25.1% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRDA logo

CRDA: Mixed Broker Revisions And Execution Risks Will Shape Future P/E Path

Fair Value: UK£28.65 12.4% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRDA logo

CRDA: Margin Execution And Multiple Support Will Drive Reappraisal Over Time

Fair Value: UK£35.8 10.0% undervalued intrinsic discount
25 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential and pays a dividend.

2 Risks
2 Rewards

Croda International Plc Key Details

UK£1.7b

Revenue

UK£970.8m

Cost of Revenue

UK£753.3m

Gross Profit

UK£673.8m

Other Expenses

UK£79.5m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Feb 23, 2027
0.57
43.69%
4.61%
32.2%
View Full Analysis

About CRDA

Founded
1925
Employees
5954
CEO
Stephen Foots
WebsiteView website
www.croda.com

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

Recent CRDA News & Updates

Narrative Update Jul 29

CRDA: Recent Repricing Signals Future Re Rating Potential At 3,400 Level

The updated analyst price target for Croda International is now £3,400, up £50 from the prior £3,350, as analysts reflect revised fair value assumptions alongside slightly lower revenue growth and profit margin forecasts and a modestly adjusted future P/E multiple. Analyst Commentary Recent research updates on Croda International point to a more constructive tone from bullish analysts, who are refining their valuation work rather than making sweeping changes to their investment cases.

Recent updates

No updates